ALAsier Larrea-Sebal

Asier Larrea-Sebal

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Asier Larrea-Sebal has a total of 173 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    quantmsdiann: a scalable SDRF-driven DIA-NN workflow for reanalysis of single-cell, spatial, and bulk proteomics datasets

    by Qi-Xuan Yue, Yufei Shen, Chengxin Dai, Asier Larrea-Sebal, Henry Webel, Jose Nimo, Fabian Coscia, Orhun Kok, Nikolai Slavov, Juan Antonio Vizcaíno, et al.

    Public proteomics archives now hold thousands of data-independent acquisition (DIA) datasets, but reusing them is difficult: each was processed with a different software configuration, and most lack standardized metadata. Here, we present quantmsdiann, an open-source Nextflow/nf-core workflow that runs DIA-NN in parallel across cloud and high-performance computing (HPC) infrastructure, guided by the experimental design declared in SDRF format. The workflow provides pinned container profiles and builds recipes for each supported DIA-NN version under BioContainers, resolving dependencies automatically, and reads all major vendor formats and the HUPO-PSI mzML standard. It exports harmonized quantification tables as MSstats input, in the Quantitative Proteomics eXchange (QPX) format, and a pmultiqc quality-control report. The parallel design reanalyzes a 2,300-run single-cell dataset in 2.2 hours on 300 HPC nodes. We performed multiple experiments and benchmarks of quantmsdiann on single-cell datasets; ProteoBench DIA-NN single-machine submissions or public datasets in ProteomeXchange. The benchmark against ProteoBench single-machine DIA-NN modules demonstrated no differences between DIA-NN single-machine runs and parallelization in quantmsdiann; while upgrading DIA-NN from 1.8.1 to a current release increased protein-group identifications by up to 17% in single-cell datasets. Remarkably, reanalysis of public DIA datasets with quantmsdiann and the latest version of DIA-NN always exceeds the originally deposited counts, recovering up to 59% more protein groups, with the largest gains on deposits processed with older or non-DIA-NN engines and smaller gains where a recent DIA-NN release was already used. quantmsdiann is a step toward scalable, reproducible reanalysis of the growing DIA data archive and a foundation for large-scale DIA meta-analysis and atlas building. It is available at https://github.com/bigbio/quantmsdiann.


  • Open Access

    The PRIDE Affinity-Proteomics Archive (PRIDE-AP): Making Affinity Proteomics Data FAIR

    by Deepti J. Kundu, Asier Larrea-Sebal, Selvakumar Kamatchinathan, Chakradhar Bandla, Nithu Sara John, Nandana Madhusoodanan, Suresh C. Hewapathirana, Boma Brown-Harry, Jingwen Bai, Kathleen T. Nevola, et al.

    High-throughput affinity proteomics (AP) technologies, such as Olink and SomaScan, are central to biomarker discovery and clinical studies, but unlike mass spectrometry (MS)-based proteomics, they have lacked a dedicated, standards-driven open-data repository. To address this gap, we introduce the PRIDE Affinity Proteomics Archive (PRIDE-AP), a centralized, open, technology-agnostic repository extending the PRIDE infrastructure to support submission, storage, and reuse of AP datasets in compliance with FAIR principles. Each dataset receives a stable PAD identifier and DOI and undergoes automated validation. We extended the HUPO-PSI SDRF-Proteomics format and the PRIDE controlled vocabulary for AP experiments, and integrated quality-control statistics via the open-source library pyprideap. As of May 2026, PRIDE-AP includes 20 public datasets spanning 14 human diseases, with evidence for over 10,000 proteins. By enabling AP and MS datasets to be jointly deposited and linked, with protein-centric exploration cross-referenced to UniProt, PRIDE-AP enables cross-technology proteome interrogation at scale.

  • Open Access

    pmultiqc: An Open-Source, Lightweight, and Metadata-Oriented QC Reporting Library for MS Proteomics

    by Qi-Xuan Yue, Chengxin Dai, Selvakumar Kamatchinathan, Chakradhar Bandla, Henry Webel, Asier Larrea, Wout Bittremieux, Julian Uszkoreit, Tom David Müller, Jinqiu Xiao, et al.


  • Open Access

    quantms-rescoring enables deep proteome coverage across protein quantification, immunopeptidomics, and post-translational modifications experiments

    by Chengxin Dai, Ralf Gabriels, Robbin Bouwmeester, Asier Larrea, Jonas Scheid, Henry Webel, Fuchu He, Lennart Martens, Oliver Kohlbacher, Mingze Bai, et al.

    The growing volume of public proteomics datasets and the advent of novel machine learning (ML)-based methods create unprecedented opportunities for discovery through large-scale reanalysis. However, traditional desktop tools are increasingly insufficient for processing and integrating data at this scale. To address this challenge, we present a novel package, quantms-rescoring, that extends the cloud-native quantms workflow with a machine learning-based rescoring module. Unlike prior tools that rescore single-engine outputs, quantms-rescoring seamlessly integrates multiple search engines (SAGE, COMET, and MSGF+), performs automatic model selection, model fine-tuning, and scales reproducibly on cloud infrastructures. In quantms-rescoring, we rely on multiple fragment-ion intensity (AlphaPeptDeep and MS2PIP) and retention-time prediction (DeepLC) methods to improve results from multiple peptide database search engines. It features automatic model selection, fine-tuning, and retraining for MS/MS intensity and retention time prediction to select the best model for a given dataset. We applied the novel workflow to five representative datasets spanning DDA label-free quantification, TMT 10-plex isobaric labelling of tumor proteomics data, immunopeptidomics, phospho-proteomics, and unseen lysine malonylation experiments. We achieved a 16-22.8% increase in identified spectra, along with the quantification of 2191 additional phosphorylated peptides and 1337 phosphosites. In the tandem mass tag (TMT)-labeled clear cell renal cell carcinoma dataset, 76 novel differentially expressed multiple search engines identified proteins with quantms-rescoring. Additionally, novel 11,688 HLA-II potential binders were detected in the immunopeptidomics dataset by multiple search engines with quantms-rescoring. For unseen malonylation data, we reported more than 58.8% malonylation PSMs and 30.5% modification sites than COMET alone. Together, these results show that integrating multi-engine searches with machine learning-derived features can be combined in a scalable workflow that enhances identification, PTM localization, and quantification performance.

  • Open Access

    Impact of Biotechnology on Sustainable Development: An Opinion Analysis

    by Alejandro Leiva, Asier Larrea-Sebal, Arantzazu Acha, Lidia Ruth Montes

    Biotechnology is increasingly recognized as a key driver for achieving the United Nations 2030 Agenda and its Sustainable Development Goals (SDGs). However, public awareness of its role remains uncertain. This study aimed to assess the knowledge, perceptions and opinions regarding the relationship between the SDGs and biotechnology among the general adult population in Spain. A validated online survey was distributed, yielding 274 responses. Although 84.3% of the respondents were familiar with the 2030 Agenda, positive perceptions of the SDGs were especially common among women and individuals with higher levels of education. Regarding biotechnology, 54.4% considered themselves knowledgeable, and nearly half (48.2%) recognized its potential contribution to health (SDG 3) and environmental sustainability, but its role in social and economic SDGs was less recognized. This study highlights the need for targeted educational and communication strategies to raise awareness and show how concrete biotechnological applications can contribute to sustainable development. Emphasizing these practical contributions can position biotechnology as a visible driver of progress and foster greater public engagement with science in achieving the 2030 Agenda.


  • Open Access

    pmultiqc: An open-source, lightweight, and metadata-oriented QC reporting library for MS proteomics

    by Qi-Xuan Yue, Chengxin Dai, Selvakumar Kamatchinathan, Chakradhar Bandla, Henry Webel, Asier Larrea, Wout Bittremieux, Julian Uszkoreit, Tom David Müller, Jinqiu Xiao, et al.

    The increasing scale and complexity of proteomics data demand robust, scalable, and interpretable quality control (QC) frameworks to ensure data reliability and reproducibility. Here, we present pmultiqc, an open-source Python package that standardizes and generates web-based QC reports across multiple proteomics data analysis platforms. Built on top of the widely adopted MultiQC framework, pmultiqc offers specialized modules tailored to mass spectrometry workflows, with full initial support for quantms, DIA-NN, MaxQuant/MaxDIA, and mzIdentML/mzML-based pipelines. The package computes a wide range of QC metrics, including raw intensity distributions, identification rates, retention time consistency, and missing value patterns, and presents them in interactive, publication-ready reports. By leveraging sample metadata in the SDRF format, pmultiqc enables metadata-aware QC and introduces, for the first time in proteomics, QC reports and metrics guided by standardized sample metadata. Its modular architecture allows easy extension to new workflows and formats. Alongside comprehensive documentation and examples for running pmultiqc locally or integrated into existing workflows, we offer a cloud-based service that enables users to generate QC reports from their own data or public PRIDE datasets.


  • Open Access

    Predictive Modeling and Structure Analysis of Genetic Variants in Familial Hypercholesterolemia: Implications for Diagnosis and Protein Interaction Studies

    by Asier Larrea-Sebal, Shifa Jebari-Benslaiman, Unai Galicia-Garcia, Ane San Jose-Urteaga, Kepa B. Uribe, Asier Benito-Vicente, César Martín

    Purpose of Review: Familial hypercholesterolemia (FH) is a hereditary condition characterized by elevated levels of low-density lipoprotein cholesterol (LDL-C), which increases the risk of cardiovascular disease if left untreated. This review aims to discuss the role of bioinformatics tools in evaluating the pathogenicity of missense variants associated with FH. Specifically, it highlights the use of predictive models based on protein sequence, structure, evolutionary conservation, and other relevant features in identifying genetic variants within LDLR, APOB, and PCSK9 genes that contribute to FH. Recent Findings: In recent years, various bioinformatics tools have emerged as valuable resources for analyzing missense variants in FH-related genes. Tools such as REVEL, Varity, and CADD use diverse computational approaches to predict the impact of genetic variants on protein function. These tools consider factors such as sequence conservation, structural alterations, and receptor binding to aid in interpreting the pathogenicity of identified missense variants. While these predictive models offer valuable insights, the accuracy of predictions can vary, especially for proteins with unique characteristics that might not be well represented in the databases used for training. Summary: This review emphasizes the significance of utilizing bioinformatics tools for assessing the pathogenicity of FH-associated missense variants. Despite their contributions, a definitive diagnosis of a genetic variant necessitates functional validation through in vitro characterization or cascade screening. This step ensures the precise identification of FH-related variants, leading to more accurate diagnoses. Integrating genetic data with reliable bioinformatics predictions and functional validation can enhance our understanding of the genetic basis of FH, enabling improved diagnosis, risk stratification, and personalized treatment for affected individuals. The comprehensive approach outlined in this review promises to advance the management of this inherited disorder, potentially leading to better health outcomes for those affected by FH.


  • Dislipidemiaren aurkako tratamentu berriak nanopartikulak erabiliz

    by Cesar Martin Plagaro, Unai Galicia Garcia, Kepa B. Uribe, Asier Benito Vicente, Shifa Jebari Benslaiman, Asier Larrea Sebal, Ane San José Urteaga

    Dislipidemiaren aurkako tratamentu berriak nanopartikulak erabiliz produkzioaren informazio-fitxa

  • Kolesterol-kanporaketaren estimulazioa ateroma ereduan, rHDLen administrazio sekuentzialarekin

    by Cesar Martin Plagaro, Koen Vandenbroeck, Iraide Alloza Moral, Ane San José Urteaga, Asier Larrea Sebal, Unai Galicia Garcia, Asier Benito Vicente, Kepa B. Uribe, Shifa Jebari Benslaiman

    Kolesterol-kanporaketaren estimulazioa ateroma ereduan, rHDLen administrazio sekuentzialarekin produkzioaren informazio-fitxa